BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35846330)

  • 1. Total Flavonoids of Drynariae Rhizoma Improve Glucocorticoid-Induced Osteoporosis of Rats: UHPLC-MS-Based Qualitative Analysis, Network Pharmacology Strategy and Pharmacodynamic Validation.
    Zhang F; Li Q; Wu J; Ruan H; Sun C; Zhu J; Song Q; Wei X; Shi Y; Zhu L
    Front Endocrinol (Lausanne); 2022; 13():920931. PubMed ID: 35846330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active components and mechanisms of total flavonoids from Rhizoma Drynariae in enhancing cranial bone regeneration: An investigation employing serum pharmacochemistry and network pharmacology approaches.
    Zhao Y; Cai X; Sun J; Bi W; Yu Y
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117253. PubMed ID: 37778522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Mechanism of Total Flavonoids of Drynariae Rhizoma to Improve Large Bone Defects by Network Pharmacology and Experimental Assessment.
    Sun W; Li M; Xie L; Mai Z; Zhang Y; Luo L; Yan Z; Li Z; Dong H; Huang F; Shen Z; Jiang Z
    Front Pharmacol; 2021; 12():603734. PubMed ID: 34149403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney tissue targeted metabolic profiling of glucocorticoid-induced osteoporosis and the proposed therapeutic effects of Rhizoma Drynariae studied using UHPLC/MS/MS.
    Huang Y; Liu X; Zhao L; Li F; Xiong Z
    Biomed Chromatogr; 2014 Jun; 28(6):878-84. PubMed ID: 24861758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Flavonoids of Drynariae Rhizoma Prevent Bone Loss Induced by Hindlimb Unloading in Rats.
    Song S; Gao Z; Lei X; Niu Y; Zhang Y; Li C; Lu Y; Wang Z; Shang P
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28640230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats.
    Yang Y; Nian H; Tang X; Wang X; Liu R
    J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide increases bone formation and inhibits bone resorption in rats with glucocorticoid-induced osteoporosis.
    Yang L; Yang J; Pan T; Zhong X
    J Endocrinol Invest; 2019 Sep; 42(9):1125-1131. PubMed ID: 30955181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total flavonoids of rhizoma drynariae ameliorates bone formation and mineralization in BMP-Smad signaling pathway induced large tibial defect rats.
    Sun W; Li M; Zhang Y; Huang Y; Zhan Q; Ren Y; Dong H; Chen J; Li Z; Fan C; Huang F; Shen Z; Jiang Z
    Biomed Pharmacother; 2021 Jun; 138():111480. PubMed ID: 33774316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Flavonoids from
    Fang XH; Zhou GE; Lin N
    Comb Chem High Throughput Screen; 2023; 26(13):2401-2409. PubMed ID: 36825725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhizoma drynariae total flavonoids combined with calcium carbonate ameliorates bone loss in experimentally induced Osteoporosis in rats via the regulation of Wnt3a/β-catenin pathway.
    Hu Y; Mu P; Ma X; Shi J; Zhong Z; Huang L
    J Orthop Surg Res; 2021 Dec; 16(1):702. PubMed ID: 34863225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics analysis of the potential mechanism of Yi-Guan-Jian decoction to reverse bone loss in glucocorticoid-induced osteoporosis.
    Yin M; Zhou D; Jia F; Su X; Li X; Sun R; Li J
    J Orthop Surg Res; 2023 Jun; 18(1):409. PubMed ID: 37277810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabonomic study on the anti-osteoporosis effect of Rhizoma Drynariae and its action mechanism using ultra-performance liquid chromatography-tandem mass spectrometry.
    Liu X; Zhang S; Lu X; Zheng S; Li F; Xiong Z
    J Ethnopharmacol; 2012 Jan; 139(1):311-7. PubMed ID: 22120013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms and therapeutics of glucocorticoid-induced osteoporosis].
    Kaneko K; Kawai S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(3):138-48. PubMed ID: 21720102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventional value of total flavonoids from Rhizoma Drynariae on Cathepsin K, a potential target of osteoporosis.
    Shi XL; Liu K; Wu LG
    Chin J Integr Med; 2011 Jul; 17(7):556-60. PubMed ID: 21725884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network Pharmacology-Based Pharmacological Mechanism of the Chinese Medicine Rhizoma drynariae Against Osteoporosis.
    Gan D; Xu X; Chen D; Feng P; Xu Z
    Med Sci Monit; 2019 Aug; 25():5700-5716. PubMed ID: 31368456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway.
    Zhang X; Chen K; Wei B; Liu X; Lei Z; Bai X
    Chem Biol Interact; 2016 Aug; 256():188-97. PubMed ID: 27387537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Total Flavonoids of Rhizoma Drynariae in Treating Rheumatoid Arthritis.
    Chen GY; Luo J; Liu Y; Yu XB; Liu XY; Tao QW
    Drug Des Devel Ther; 2022; 16():1743-1766. PubMed ID: 35702063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on mechanism of Drynariae Rhizoma in treating osteoporosis with integrative pharmacology perspective].
    Zhang YL; Tang B; Jiang JJ; Shen H; Xie YM; Wei X
    Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(20):4125-4131. PubMed ID: 30486541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics profiling provides valuable insights into the underlying mechanisms of Morinda officinalis on protecting glucocorticoid-induced osteoporosis.
    Xia T; Dong X; Lin L; Jiang Y; Ma X; Xin H; Zhang Q; Qin L
    J Pharm Biomed Anal; 2019 Mar; 166():336-346. PubMed ID: 30690247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gu Sui Bu (Drynaria fortunei J. Sm.) antagonizes glucocorticoid-induced mineralization reduction in zebrafish larvae by modulating the activity of osteoblasts and osteoclasts.
    Peng CH; Lin WY; Li CY; Dharini KK; Chang CY; Hong JT; Lin MD
    J Ethnopharmacol; 2022 Oct; 297():115565. PubMed ID: 35863613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.